Related Experiment Video

Updated: Aug 19, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Rapidly advancing invasive endomyocardial aspergillosis

Vedat Davutoglu1, Serdar Soydinc, Abdullah Aydin

  • 1Departments of Cardiology and Pathology, Gaziantep University School of Medicine, Sahinbey Medical Center, TR-27310 Sahinbey/Gaziantep, Turkey. davutoglu@gantep.edu.tr

Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|February 1, 2005
PubMed

Insights

Invasive endomyocardial aspergillosis, a rare fungal infection, occurred in a non-immunocompromised patient due to prolonged broad-spectrum antibiotic use. This case highlights the risk of opportunistic fungal infections in unexpected patient populations.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Cardiology

Background:

  • Aspergillus spore exposure is common, but invasive disease typically affects immunocompromised individuals.
  • Broad-spectrum antibiotic use can disrupt the microbiome, potentially increasing susceptibility to opportunistic infections.

Observation:

  • A 36-year-old cotton textile worker presented with weight loss and fatigue after prolonged antibiotic treatment.
  • Echocardiography revealed endomyocardial vegetations and a left atrial mass.
  • Myocardial biopsy confirmed invasive endomyocardial aspergillosis.

Findings:

  • The patient was non-immunocompromised, with negative investigations for immune deficiency including HIV.
  • Treatment with amphotericin B and heparin was initiated.
  • The patient succumbed to a ruptured mycotic aneurysm leading to cerebral hemorrhage.

Implications:

  • This case underscores the potential for invasive fungal infections, such as aspergillosis, in non-immunocompromised hosts with prolonged antibiotic exposure.
  • Environmental exposure to Aspergillus, combined with antibiotic-induced dysbiosis, may create a risk for opportunistic infections.
  • Highlights the need for vigilance regarding fungal infections in patients with atypical risk factors.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...